These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17449467)

  • 1. Structural and functional characterization of a novel T cell receptor co-regulatory protein complex, CD97-CD55.
    Abbott RJ; Spendlove I; Roversi P; Fitzgibbon H; Knott V; Teriete P; McDonnell JM; Handford PA; Lea SM
    J Biol Chem; 2007 Jul; 282(30):22023-32. PubMed ID: 17449467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costimulation via CD55 on human CD4+ T cells mediated by CD97.
    Capasso M; Durrant LG; Stacey M; Gordon S; Ramage J; Spendlove I
    J Immunol; 2006 Jul; 177(2):1070-7. PubMed ID: 16818763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the EGF-TM7 receptor CD97 and its ligand CD55 (DAF) in multiple sclerosis.
    Visser L; de Vos AF; Hamann J; Melief MJ; van Meurs M; van Lier RA; Laman JD; Hintzen RQ
    J Neuroimmunol; 2002 Nov; 132(1-2):156-63. PubMed ID: 12417446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the largest CD97 and EMR2 isoforms on leukocytes facilitates a specific interaction with chondroitin sulfate on B cells.
    Kwakkenbos MJ; Pouwels W; Matmati M; Stacey M; Lin HH; Gordon S; van Lier RA; Hamann J
    J Leukoc Biol; 2005 Jan; 77(1):112-9. PubMed ID: 15498814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for CD97 recognition of the decay-accelerating factor CD55 suggests mechanosensitive activation of adhesion GPCRs.
    Niu M; Xu S; Yang J; Yao D; Li N; Yan J; Zhong G; Song G
    J Biol Chem; 2021; 296():100776. PubMed ID: 33992645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human EMR2, a novel EGF-TM7 molecule on chromosome 19p13.1, is closely related to CD97.
    Lin HH; Stacey M; Hamann J; Gordon S; McKnight AJ
    Genomics; 2000 Jul; 67(2):188-200. PubMed ID: 10903844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the CD55 (DAF)-binding site on the seven-span transmembrane receptor CD97.
    Hamann J; Stortelers C; Kiss-Toth E; Vogel B; Eichler W; van Lier RA
    Eur J Immunol; 1998 May; 28(5):1701-7. PubMed ID: 9603477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD97 isoform expression in leukocytes.
    Eichler W
    J Leukoc Biol; 2000 Oct; 68(4):561-7. PubMed ID: 11037979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD97-decay-accelerating factor interaction is not involved in leukocyte adhesion to endothelial cells.
    Boulday G; Hamann J; Soulillou JP; Charreau B
    Transplantation; 2002 Feb; 73(3):429-36. PubMed ID: 11884941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human EGF-TM7 family member EMR2 is a heterodimeric receptor expressed on myeloid cells.
    Kwakkenbos MJ; Chang GW; Lin HH; Pouwels W; de Jong EC; van Lier RA; Gordon S; Hamann J
    J Leukoc Biol; 2002 May; 71(5):854-62. PubMed ID: 11994511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF).
    Hamann J; Vogel B; van Schijndel GM; van Lier RA
    J Exp Med; 1996 Sep; 184(3):1185-9. PubMed ID: 9064337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the epidermal growth factor-TM7 receptor EMR2 and its ligand dermatan sulfate in rheumatoid synovial tissue.
    Kop EN; Kwakkenbos MJ; Teske GJ; Kraan MC; Smeets TJ; Stacey M; Lin HH; Tak PP; Hamann J
    Arthritis Rheum; 2005 Feb; 52(2):442-50. PubMed ID: 15693006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of CD97 and CD55 in human medullary thyroid carcinomas.
    Mustafa T; Klonisch T; Hombach-Klonisch S; Kehlen A; Schmutzler C; Koehrle J; Gimm O; Dralle H; Hoang-Vu C
    Int J Oncol; 2004 Feb; 24(2):285-94. PubMed ID: 14719104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular analysis of the epidermal growth factor-like short consensus repeat domain-mediated protein-protein interactions: dissection of the CD97-CD55 complex.
    Lin HH; Stacey M; Saxby C; Knott V; Chaudhry Y; Evans D; Gordon S; McKnight AJ; Handford P; Lea S
    J Biol Chem; 2001 Jun; 276(26):24160-9. PubMed ID: 11297558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of CD97 in regulating adaptive T-cell responses.
    Spendlove I; Sutavani R
    Adv Exp Med Biol; 2010; 706():138-48. PubMed ID: 21618833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural characterization of mouse CD97 and study of its specific interaction with the murine decay-accelerating factor (DAF, CD55).
    Qian YM; Haino M; Kelly K; Song WC
    Immunology; 1999 Oct; 98(2):303-11. PubMed ID: 10540231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical expression and prognostic value of CD97 and its ligand CD55 in primary gallbladder carcinoma.
    Wu J; Lei L; Wang S; Gu D; Zhang J
    J Biomed Biotechnol; 2012; 2012():587672. PubMed ID: 22547928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human CD46 rather than CD55 is a key element in protection against complement activation in vitro.
    van Dixhoorn MG; Dekker S; Janssen RW; Verbakel CA; Grosveld F
    Transplant Proc; 2000 Aug; 32(5):916-8. PubMed ID: 10936272
    [No Abstract]   [Full Text] [Related]  

  • 19. Complement decay accelerating factor (DAF)/CD55 in cancer.
    Spendlove I; Ramage JM; Bradley R; Harris C; Durrant LG
    Cancer Immunol Immunother; 2006 Aug; 55(8):987-95. PubMed ID: 16485129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue distribution of the human CD97 EGF-TM7 receptor.
    Jaspars LH; Vos W; Aust G; Van Lier RA; Hamann J
    Tissue Antigens; 2001 Apr; 57(4):325-31. PubMed ID: 11380941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.